Griscelli syndrome type 1

Overview

Griscelli syndrome type 1 (GS1) is a very rare inherited disorder that affects several body systems, most notably skin and hair pigmentation, and neurological function. It is one of several types of Griscelli syndrome, each caused by different genetic changes and presenting with a distinct set of symptoms [PMID:11933096]. Individuals with GS1 generally have characteristic silvery-grey hair and lighter skin colour, a form of partial albinism, due to issues with pigment distribution in cells. This condition typically becomes apparent in early childhood.

Symptoms & clinical features

The main symptoms of Griscelli syndrome type 1 include features of partial albinism, such as abnormally light, silvery-grey hair and lighter skin [PMID:10729227]. However, unlike some other forms of albinism, the eyes are typically not as severely affected, though some individuals may have reduced vision or involuntary eye movements (nystagmus). The most significant and distinguishing symptoms of GS1 relate to neurological impairment. These can be progressive and vary in severity, potentially including developmental delay, intellectual disability, muscle weakness, difficulties with coordination and balance, and seizures. Some affected individuals may also experience speech difficulties.

Video: Genetics 101

Affected organs

Griscelli syndrome type 1 primarily affects the skin, hair, and the nervous system. The pigment-producing cells (melanocytes) are present in the skin and hair follicles, but they struggle to transport pigment correctly, leading to the characteristic hypopigmentation. The central nervous system is profoundly affected, leading to a range of neurological symptoms. Other organs are generally not directly affected by GS1, though complications arising from neurological impairment can indirectly impact overall health.

Brain

Central nervous system involvement

Cellular impact

Mechanism at cellular level

Risks & severity

Griscelli syndrome type 1 is a severe condition. The neurological symptoms are often progressive and can lead to significant disability. The severity of neurological involvement can vary between individuals, but typically, cognitive and motor development are impaired. Without appropriate management and support, the neurological complications can be life-limiting. As a very rare condition, precise prevalence figures for GS1 are not well established in the UK population.

Genetic causes

Griscelli syndrome type 1 is a genetic condition caused by pathogenic variants in the MYO5A gene. The MYO5A gene provides instructions for making a protein called myosin-Va [PMID:10729227]. This protein is crucial for the movement and distribution of melanosomes, which are small compartments within cells that contain the pigment melanin. In individuals with GS1, alterations in MYO5A disrupt the normal transport of melanosomes to skin and hair cells, resulting in the characteristic light hair and skin. Furthermore, the myosin-Va protein also plays a vital role in the proper functioning of nerve cells, and its disruption leads to the neurological symptoms observed in GS1 [PMID:11933096].

Inheritance pattern

Griscelli syndrome type 1 is inherited in an autosomal recessive pattern. This means that a child must inherit two altered copies of the causative gene - one from each parent - to develop the condition. Parents who each carry one altered copy of the gene are known as carriers; they typically do not show symptoms themselves. If both parents are carriers, there is a 25% (or 1 in 4) chance with each pregnancy that their child will inherit two altered copies and develop GS1. There is also a 50% chance that the child will be a carrier like their parents, and a 25% chance that the child will inherit two unaffected copies of the gene.

Diagnosis & testing

The diagnosis of Griscelli syndrome type 1 is initially based on observing the characteristic clinical features, including the silvery-grey hair, partial albinism, and neurological symptoms. A definitive diagnosis often involves genetic testing to identify the specific genetic changes responsible for the condition [PMID:10729227]. In the UK, if GS1 is suspected, a general practitioner (GP) would typically refer an individual to a paediatrician or a clinical geneticist. Genetic testing for rare conditions like GS1 falls under the NHS Genomic Medicine Service, often initiated following referral to a clinical genetics service. These services utilise specific R-codes for testing, although for very rare conditions, the exact R-code may be determined during the referral process. Skin or hair microscopy may also be used to look for characteristic abnormalities in pigment distribution [PMID:11933096].

Management & lifestyle

Management of Griscelli syndrome type 1 focuses on addressing the symptoms and providing supportive care, as there is currently no cure for the underlying genetic cause. A multidisciplinary team of specialists is often involved, including paediatricians, neurologists, geneticists, ophthalmologists, and physiotherapists. Regular monitoring of neurological development is important, and therapies such as physiotherapy, occupational therapy, and speech and language therapy can help manage developmental delays and improve motor skills. Anti-epileptic medications may be prescribed if seizures occur. Skin and hair care advice, including sun protection, is also important due to the partial albinism. Genetic counsellors can provide essential information and support to families regarding inheritance patterns, risks for future pregnancies, and coping strategies.

UK care pathway

In the UK, individuals suspected of having a rare genetic condition like Griscelli syndrome type 1 would typically be referred by their GP to a specialist, such as a paediatrician or a clinical geneticist. These specialists work within the NHS Genomic Medicine Service (GMS) framework. The GMS offers a pathway for genomic testing, which is crucial for confirming diagnoses of rare genetic disorders. Patients and their families will also have access to genetic counselling services, which provide information, support, and guidance on understanding the condition, its inheritance, and implications for the wider family. Genetic counsellors can explain the testing process, results, and help families navigate the complex emotional and practical aspects of living with a genetic condition.

Related conditions

Griscelli syndrome is a group of related conditions, and it is important to distinguish between the different types. Griscelli syndrome type 2, for example, is also characterised by partial albinism but is primarily associated with immune system problems rather than severe neurological issues. Another related condition is Chédiak-Higashi syndrome, which also involves partial albinism and immune dysfunction, alongside some neurological features. These conditions share some overlapping features, particularly pigmentation abnormalities, but differ significantly in their genetic causes and the primary organ systems affected, making accurate diagnosis critical for appropriate management.

Frequently asked questions

References

1. Khorram E, Tabatabaiefar MA, Yaghini O. Griscelli syndrome type 1: a novel pathogenic variant, and review of literature. Molecular genetics and genomics : MGG. 2023. PMID: 36651988
2. Christen M, de le Roi M, Jagannathan V. MYO5A Frameshift Variant in a Miniature Dachshund with Coat Color Dilution and Neurological Defects Resembling Human Griscelli Syndrome Type 1. Genes. 2021. PMID: 34680875
3. Gupta J, Sharma P, Ameta P. Griscelli Syndrome Type 1: Hair Microscopy Clinches the Diagnosis. Indian journal of pediatrics. 2023. PMID: 36512299
4. Thomas ER, Walker LJ, Pullaperuma S. Griscelli syndrome type 1: a report of two cases and review of the literature. Clinical dysmorphology. 2009. PMID: 19318926
5. AmirKashani D, Hosseini S, Mojbafan M. A Novel MYO5A Mutation (c.3508C>T) in a 27-Month-Old Girl With Hypotonia and Developmental Delay: Expanding the Phenotypic Spectrum of Griscelli Syndrome Type 1. Case reports in immunology. 2026. PMID: 42376587
6. Takagishi Y, Murata Y. Myosin Va mutation in rats is an animal model for the human hereditary neurological disease, Griscelli syndrome type 1. Annals of the New York Academy of Sciences. 2006. PMID: 17185506
7. Reissmann M, Ludwig A. Pleiotropic effects of coat colour-associated mutations in humans, mice and other mammals. Seminars in cell & developmental biology. 2013. PMID: 23583561
8. Timson DJ. Myosin Va and spermine synthase: partners in exosome transport. Bioscience reports. 2019. PMID: 30967493